Opthalmic compositions and methods for treating ophthalmic conditions

Details for Australian Patent Application No. 2005271700 (hide)

Owner Allergan, Inc.

Inventors Whitcup, Scott M.

Agent Davies Collison Cave

Pub. Number AU-B-2005271700

PCT Pub. Number WO2006/017347

Priority 60/587,092 12.07.04 US

Filing date 11 July 2005

Wipo publication date 16 February 2006

Acceptance publication date 11 November 2010

International Classifications

A61K 31/573 (2006.01)

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017347 Priority application(s): WO2006/017347

11 November 2010 Application Accepted

  Published as AU-B-2005271700

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271703-Safety harnesses

2005271693-Reactivity drift and catalyst degradation in polyurethane foam